Regenerative Medicine: Regulatory, Legal, and Compliance Challenges for Cell and Gene Therapies

June 8–9, 2021 | Virtual Event

Regenerative Medicine: Regulatory, Legal, and Compliance Challenges for Cell and Gene Therapies2021-06-10T10:52:27-04:00

FDA Drug Manufacturing Oversight During Covid-19: The GAO Report on the Inspections Backlog and Steps FDA is Taking to Address It

Update Magazine | Summer 2021

FDA Drug Manufacturing Oversight During Covid-19: The GAO Report on the Inspections Backlog and Steps FDA is Taking to Address It2022-03-18T11:46:40-04:00

How Does FDA’s Recent Guidance on Remote Interactive Evaluations Change the Inspections Landscape?

Recorded May 26, 2021 | On-Demand Webinar

How Does FDA’s Recent Guidance on Remote Interactive Evaluations Change the Inspections Landscape?2024-07-19T11:42:18-04:00
Go to Top